MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is making further strides in its commitment to driving significant sustainability improvements in its packaging. Now in its fourth year, the company’s industry-first SMASH Packaging Plan continues to set new standards and goals for packaging while still meeting the required performance requirements and transit safety regulations.

The SMASH Packaging Plan is founded on three pillars:

• Optimize resources by reducing the amount of packaging
• Utilize more sustainable materials to achieve zero-deforestation and increase plastic sustainability in packaging
• Design for the circular economy to maximize recyclability and reduce waste

In its annual progress report, MilliporeSigma revealed the global Life Science business sector is on track to achieve several of its initiatives by the end of 2022. Since the launch of the SMASH Packaging Plan, the company was able to:

• Reduce more than 250 metric tons of packaging waste annually through 15 product and distribution improvement projects to existing packaging. Additionally, several of the company’s distribution centers completed the Packaging for Smalls project, which enables more efficient packaging. It will result in an annual reduction of 65+ metric tons of packaging by the end of 2022.
• Complete 10 improvement projects at multiple locations to replace existing plastic packaging with more sustainable solutions
• Ensure 71% of its fiber-based packaging materials sourced directly align with the company’s zero-deforestation standards. This represents an 8% increase from 2019.
• Add sustainable forestry certification to 800 metric tons of corrugated and paperboard materials
• Replace 70 metric tons of non-recyclable edge protectors with a 100% paper-based alternative
• Implement a new process for the reuse of wood pallets—resulting in the avoidance of 1,000 metric tons of wood pallets sourced annually
• Utilize three million molded pulp inserts for its glass bottle reagents instead of expanded polystyrene (EPS), which is difficult to recycle. Company rollout of new greener coolers in the U.S. is also expected by the end of 2022, resulting in an annual EPS reduction of 5,000+ cubic meters.

Additionally, MilliporeSigma is currently developing recycling and disposal guidance for its packaging materials to help its customers to manage them more responsibly. The first version of this solution is expected to be completed by the end of 2022.

To learn more about the Life Science business sector’s SMASH Packaging Plan and how the company is contributing toward a healthier ecosystem through sustainable product and packaging improvements, read the 2021 annual report.

MilliporeSigma

MilliporeSigma

We holistically integrate sustainability throughout our own operations and across suppliers, reducing the impact of scientific research globally and exceeding customer expectations.

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 26,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.  

Around 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2024, Merck KGaA, Darmstadt, Germany, generated sales of € 21.2 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

More from MilliporeSigma